Transformative technologies that drive growth and jobs will benefit from new investment by the government's national research funder.
Engineering Biology has the potential to solve some of our biggest global challenges. From developing new vaccines and therapies, to plastic-free packaging and sustainable, animal-free and protein-rich food.
Imperial aims to create new investment-ready collaborations between academics and industry working in Engineering Biology, thanks to a programme that has received £3 million investment from UK Research and Innovation (UKRI).
The programme is open now and will be delivered through the SynbiCITE Innovation and Knowledge Centre (IKC), based at Imperial College London's White City DeepTech Campus, part of the WestTech Coridor.
Successful applicants for the 'proof of concept' programme will have access to SynbiCITE's state of the art facilities like The London Biofoundry, providing a suite of equipment and training.
Projects will demonstrate significant commercial potential and have been taken to a stage where their further validation of the technical, market or commercial aspects make them attractive for investment by investors or product development by industry.
